Clinical trial
Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in…
NCT00103584 · VaxGen, Industry · Unknown status
Key facts
| NCT number | NCT00103584 |
|---|---|
| Title | Safety and Immunogenicity Study of LC16m8, a Modified Smallpox Vaccine, in Healthy, Previously Unvaccinated Volunteers |
| Official title | A Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of LC16m8, A Modified Vaccinia Vaccine, in Healthy Volunteers |
| Lead sponsor | VaxGen, Industry |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Smallpox |
| Intervention type | Biological |
| Interventions | LC16m8 Smallpox Vaccine |
| Enrollment | 150 |
| Start date | Oct 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Feb 11, 2005 |
| Last update posted | Jan 15, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: